Invitation
Welcome to the 3rd Annual Skin Basics for Primary Care Conference
We are pleased to invite Primary Care Practitioners to join us for the 3rd Annual Skin Basics for Primary Care (SBPC) Conference, taking place in September 2026 at the Toronto Marriott Markham. This full-day program is designed specifically to support primary care clinicians looking to strengthen their dermatology knowledge and confidence.
Our faculty of expert dermatologists will cover essential fundamentals, practical approaches, and updates on new and emerging treatments relevant to everyday practice. Join us for an engaging day of learning, discussion, and skill-building as we explore the core elements of dermatologic care together.
We look forward to welcoming you and supporting your continued excellence in patient care.
Your Co-Chairs,
Dr. Patrick Fleming, BSc(Nutrition), MSc(Community Health), MD, FRCPC
Dermatologist & Investigator, York Dermatology & Research Centre
Dr. Kyle O. Lee, BMLSc, BMBS, MPH, CCFP
Assistant Professor, Department of Family & Community Medicine, University of Toronto
Who Should Attend
- General practitioners
- Family physicians
- Pediatricians
- Nurse practitioners
- Physician assistants
- Pharmacists
- Medical trainees
September 19, 2026
Toronto Marriott Markham Markham, ON
The 3rd Annual SBPC Conference will take place at the Toronto Marriott Markham, a modern, upscale hotel located in the heart of Downtown Markham. The hotel’s contemporary meeting facilities provide an ideal setting for the SBPC, offering a comfortable and professional environment for learning and collaboration. Free parking is available to delegates driving in for the day.
If you would like to stay overnight at the hotel, please make your reservation directly with the hotel. For your convenience, the booking link is provided below.
Address: 170 Enterprise Boulevard Markham, Ontario
Registration
Registration is now open!
All fees are in Canadian dollars and subject to taxes of 13% HST. Registration includes continental breakfast, lunch and parking.
| REGULAR – to Sept 12 |
LATE – Sept 12 – 19 |
|
| Primary Care Practitioner | $90.00 | $130.00 |
| Industry Sponsor* | $265.00 | $370.00 |
*Sponsoring companies may purchase up to 2 additional registrations for representatives.
All registration fees will be refunded less a $20.00 + applicable taxes for refund requests received on or prior to August 21, 2026. No refunds will be available for cancellations received on or after August 22, 2026. All requests must be received in writing. No telephone cancellations will be accepted. Submit cancellation letters to the Conference Secretariat at the email noted above.
Questions?
If you have any questions, please contact the Conference Secretariat by email at [email protected] or by phone at (604) 738-8600.
Sponsors
.
2026 DIAMOND SPONSORS
With the belief that patients deserve better than the current standard of care, the Arcutis team brings a sense of urgency, simplifying disease management and optimizing drug efficacy, safety, and tolerability to meet the needs of healthcare providers and patients. Arcutis has the potential to advance the standard of care for plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis.
Bausch Health, Canada Inc., headquartered in Laval, Quebec, is part of Bausch Health Companies Inc. (NYSE/TSX: BHC), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes. Bausch Health, Canada Inc. is a leader in the medical dermatology market in Canada and provides treatments for chronic weight management, allergy, neuroscience, and cardio-metabolic conditions. Our two manufacturing facilities in Canada are for prescription pharmaceuticals, including many of our leading dermatological products. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees, and investors.
Learn more at www.bauschhealth.ca. Information for Canadian health professionals is available at www.bauschhealthresources.ca.
2026 GOLD SPONSORS
Beiersdorf Canada is one of more than 150 international affiliates of the cosmetics company Beiersdorf AG which is based in Hamburg, Germany. For over 130 years, we have dedicated ourselves to meeting our consumers’ individual needs and are considered to be the inventors of modern skin care. Our international success is founded on our research and development expertise, our innovative products, and our strong brands. Beiersdorf’s NIVEA is the world’s No.1 skin care brand*. Other names in its successful international brand portfolio include Eucerin, La Prairie, Labello, 8×4, and Hansaplast. Subsidiary tesa SE is one of the world’s leading producers of self-adhesive products and system solutions for industry, craft businesses, and consumers.
Cipher (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.
Our brands CeraVe, La Roche-Posay, SkinBetter, SkinCeuticals and Vichy, offer a broad range of options to address the health and beauty of everyone, everywhere.
LEO Pharma is a global leader in medical dermatology. We deliver innovative solutions for skin health, building on a century of experience with breakthrough medicines in healthcare. We are committed to making a fundamental difference in people’s lives, and our broad portfolio of treatments serves close to 100 million patients in over 70 countries annually. Headquartered in Denmark, LEO Pharma has a team of 4,000 people worldwide. LEO Pharma is co-owned by majority shareholder the LEO Foundation and, since 2021, Nordic Capital. For more information, visit www.leo-pharma.com.
Sanofi Regeneron are collaborating in the field of dermatology to transform the lives of patients with inflammatory skin diseases. This strategic partnership combines Regeneron’s scientific expertise in monoclonal antibodies with Sanofi’s global development and commercialization capabilities. Together, they have developed Dupixent, an innovative treatment that specifically targets type 2 inflammatory pathways involved in several dermatological conditions. Their commitment to ongoing research and therapeutic innovation aims to address the unmet needs of patients suffering from chronic dermatological diseases and improve their quality of life.
2026 SILVER SPONSORS
Incyte is a global biopharmaceutical company based in Wilmington, Delaware focused on finding solutions that can address significant unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For more information about Incyte, please visit Incyte.com and follow @Incyte.To learn more about Incyte Biosciences Canada, visit: https://incytebiosciences.ca.
As part of the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good every day. In partnership with skin experts and dermatologists, we create innovative products that include treatments for acne and eczema, gentle skin-loving cleansers, moisturizers that repair the skin barrier and sunscreens that defend against inflammation, premature aging, and skin cancer.
